News Articles
Depo-Provera, Depo-SubQ Provera, and an Authorized Generic Version Linked to Increased Risk of Meningioma—You May Be Entitled to Compensation
A recent study, “Use of Progestogens and the Risk of Intracranial Meningioma: National Case-Control Study,” published in The British Medical Journal (BMJ) — one of the world’s most trusted medical journals—has uncovered a concerning link between Depo-Provera, a popular birth control shot, and a higher risk of developing meningioma, a type of brain tumor. The study examined over 108,000 women in France and found that those using Depo-Provera, which contains medroxyprogesterone acetate, were more than five times as likely to develop this tumor, especially after using the shot for a year or more.
If you or a loved one have been diagnosed with meningioma after using Depo-Provera, you may be entitled to compensation. Meningiomas, while often non-cancerous, can cause serious health problems and require surgery or other treatments. Our law firm specializes in cases like these, and we are here to help you get the justice and financial compensation you deserve. Contact us today for a free consultation to learn about your rights and how we can assist you in holding the drug manufacturer accountable for the harm caused. Don’t wait—time may be limited to file your claim.